This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Multiple Sclerosis
and you are
between 18 and 60
years old
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

MicroRNAs regulate gene expression. The abnormal expression of microRNAs has been reported in many human diseases. The purpose of this pilot study is to determine if microRNA expression is changed in untreated and interferon-beta-treated patients with multiple sclerosis.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01587690. The sponsor of the trial is Rutgers, The State University of New Jersey and it is looking for 24 volunteers for the current phase.
Official trial title:
Immune Regulation in Multiple Sclerosis: MicroRNA and Antigen-Presenting Cells